• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Nutrition News
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Skin Diseases
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Latest News

Lawrence Eichenfield, MD | Image credit: KOL provided
Lawrence Eichenfield, MD, reacts to accepted sNDA for roflumilast cream 0.15%

November 30th 2023

Lawrence Eichenfield, MD, reacts to the FDA's acceptance of a supplemental New Drug Application for roflumilast cream 0.15% to treat atopic dermatitis (AD) in patients aged 6 years and older.

FDA warns of serious potential reaction to levetiracetam and clobazam | Image Credit: © monticellllo - © monticellllo - stock.adobe.com.
FDA warns of serious potential reaction to levetiracetam and clobazam

November 30th 2023

FDA accepts sNDA for roflumilast cream 0.15% to treat atopic dermatitis | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts sNDA for roflumilast cream 0.15% to treat atopic dermatitis

November 29th 2023

Yamo enrolls final patient of phase 2 study of L1-79 to treat symptoms of ASD | Image Credit: © Dzmitry - © Dzmitry - stock.adobe.com.
Yamo enrolls final patient of phase 2 study of L1-79 to treat symptoms of ASD

November 29th 2023

Pz-cel granted FDA Priority Review to treat recessive dystrophic epidermolysis bullosa | Image Credit: © tibanna79 - © tibanna79 - stock.adobe.com.
Pz-cel granted FDA Priority Review to treat recessive dystrophic epidermolysis bullosa

November 28th 2023

Latest Videos
Podcasts

All News

© 2023 MJH Life Sciences

All rights reserved.